Abstract:Abstract The development of prostate cancer and its progression to castrate-resistant prostate cancer (CRPC) after antiandrogen ablation therapy are driven by persistent biological activity of androgen receptor (AR) signaling. Moreover, studies have shown that more than 50% of human prostate cancers overexpress ERG (v-ets avian erythroblastosis virus E26 oncogene related gene) due to AR-regulated TMPRSS2-ERG fusion gene. However, the reported roles of TMPRSS2-ERG fusion in cancer progression are not clear. In this study, we investigated the signal transduction in the AR/TMPRSS2-ERG/Wnt signaling network for studying the aggressive behavior of prostate cancer cells and further assessed the effects of BR-DIM and CDF [natural agents-derived synthetic formulation and analogue of 3,3′-diindolylmethane (DIM) and curcumin, respectively, with improved bioavailability] on the regulation of AR/TMPRSS2-ERG/Wnt signaling. We found that activation of AR resulted in the induction of ERG expression through TMPRSS2-ERG fusion. Moreover, we found that ERG overexpression and nuclear translocation activated the activity of Wnt signaling. Furthermore, forced overexpression of ERG promoted invasive capacity of prostate cancer cells. More important, we found that BR-DIM and CDF inhibited the signal transduction in the AR/TMPRSS2-ERG/Wnt signaling network, leading to the inactivation of Wnt signaling consistent with inhibition of prostate cancer cell invasion. In addition, BR-DIM and CDF inhibited proliferation of prostate cancer cells and induced apoptotic cell death. On the basis of our findings, we conclude that because BR-DIM and CDF downregulate multiple signaling pathways including AR/TMPRSS2-ERG/Wnt signaling, these agents could be useful for designing novel strategies for the prevention and/or treatment of prostate cancer. Cancer Prev Res; 4(9); 1495–506. ©2011 AACR.

Upregulation of PAWR by Small Activating RNAs Induces Cell Apoptosis in Human Prostate Cancer Cells.

Antitumor Activity of Small Activating RNAs Induced PAWR Gene Activation in Human Bladder Cancer Cells

Promoter-targeted Double-Stranded Small RNAs Activate PAWR Gene Expression in Human Cancer Cells

DAB2IP Coordinates Both PI3K-Akt and ASK1 Pathways for Cell Survival and Apoptosis

Small RNA-induced INTS6 gene up-regulation suppresses castration-resistant prostate cancer cells by regulating β-catenin signaling.

Up-regulation of P21waf1/cip1 by Sarna Induces G1-phase Arrest and Apoptosis in T24 Human Bladder Cancer Cells.

RNAa-mediated Overexpression of WT1 Induces Apoptosis in HepG2 Cells

RNA Interference Targeting Mutant P53 Inhibits Growth and Induces Apoptosis in DU145 Human Prostate Cancer Cells

Inactivation of AR/TMPRSS2-ERG/Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells

Small Activating RNA Modulation of the G Protein‐Coupled Receptor for Cancer Treatment

Double Strand Rna-Guided Endogeneous E-Cadherin Up-Regulation Induces the Apoptosis and Inhibits Proliferation of Breast Carcinoma Cells in Vitro and in Vivo

Suppression of Migration and Invasion of PC3 Prostate Cancer Cell Line Via Activating E-Cadherin Expression by Small Activating RNA

p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell

Suppression of Bcl-xL Expression by a Novel Tumor-Specific RNA Interference System Inhibits Proliferation and Enhances Radiosensitivity in Prostatic Carcinoma Cells

Promoter-associated Small Double-Stranded RNA Interacts with Heterogeneous Nuclear Ribonucleoprotein A2/B1 to Induce Transcriptional Activation.

LncRNA LNC-565686 Promotes Proliferation of Prostate Cancer by Inhibiting Apoptosis through Stabilizing SND1

Demystifying the Mechanistic and Functional Aspects of P21 Gene Activation with Double-Stranded RNAs in Human Cancer Cells

A novel small-molecule activator of unfolded protein response suppresses castration-resistant prostate cancer growth

[Activation of P21(waf1/cip1) by Small Activating RNA Inhibits Cell Proliferation and Induces Apoptosis in BEL-7402 Hepatoma Cell].

RP1-59D14.5 triggers autophagy and represses tumorigenesis and progression of prostate cancer via activation of the Hippo signaling pathway

Pir-001773 and Pir-017184 Promote Prostate Cancer Progression by Interacting with PCDH9.